Tarsus Pharmaceuticals, Inc.
TARS
$46.47
$2.906.66%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 28.11% | 28.38% | 81.55% | 48.36% | 4.80% |
| Total Receivables | 171.31% | 375.73% | 12,436.99% | 974.74% | 394.53% |
| Inventory | -15.67% | 18,873.33% | -- | -- | -- |
| Prepaid Expenses | 86.20% | 16.78% | 19.39% | 50.88% | 65.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 39.27% | 37.74% | 97.62% | 63.30% | 13.65% |
|
|
|||||
| Total Current Assets | 39.27% | 37.74% | 97.62% | 63.30% | 13.65% |
| Net Property, Plant & Equipment | -14.40% | 15.72% | 14.46% | 100.23% | 118.54% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 115.31% | 115.96% | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 372.77% | 189.92% | 151.79% | 200.68% | 170.23% |
| Total Assets | 42.00% | 40.24% | 99.47% | 65.37% | 16.51% |
|
|
|||||
| Total Accounts Payable | 56.08% | 158.28% | 226.15% | 153.00% | 223.24% |
| Total Accrued Expenses | 37.73% | 81.44% | 38.14% | 29.10% | 50.91% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 52.76% | 49.17% | 40.37% | -16.79% | -44.80% |
| Total Finance Division Other Current Liabilities | 580.54% | 500.79% | -- | 116,914.29% | -- |
| Total Other Current Liabilities | 580.54% | 500.79% | -- | 116,914.29% | -- |
| Total Current Liabilities | 118.25% | 183.32% | 249.28% | 220.84% | 139.39% |
|
|
|||||
| Total Current Liabilities | 118.25% | 183.32% | 249.28% | 220.84% | 139.39% |
| Long-Term Debt | 140.94% | 141.38% | 190.88% | 22.10% | 53.44% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -25.61% | -20.17% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 1,648.00% |
| Total Liabilities | 122.56% | 153.93% | 202.44% | 95.89% | 95.93% |
|
|
|||||
| Common Stock & APIC | 32.36% | 37.90% | 81.82% | 81.79% | 46.37% |
| Retained Earnings | -47.23% | -66.26% | -91.73% | -112.12% | -124.94% |
| Treasury Stock & Other | 9,050.00% | 4,425.00% | -665.22% | 10.00% | 97.30% |
| Total Common Equity | 13.98% | 11.15% | 70.75% | 58.71% | 2.12% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.98% | 11.15% | 70.75% | 58.71% | 2.12% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.98% | 11.15% | 70.75% | 58.71% | 2.12% |
|
|
|||||
